Advertisement

Central Nervous System Stimulants: Neuropharmacological Mechanisms

  • E. B. Nielsen
  • J. Scheel-Krüger
Part of the Psychopharmacology Series book series (PSYCHOPHARM, volume 4)

Abstract

The mechanisms underlying CNS-stimulant drug discrimination are discussed. Although different doses of CNS stimulants may produce qualitatively different cues, it appears that a relatively low dose of d-amphetamine (e.g., 1 mg/kg) elicits a “general” CNS-stimulant cue. Presynaptically, this cue may primarily depend on release of endogeneous dopamine whereas inhibition of dopamine reuptake, per se, is insufficient to elicit the cue. Postsynaptically, the involvement of both dopamine D-1 and D-2 receptors is implicated. Furthermore, in the drug discrimination situation, D-1/D-2 receptors may be coupled differently than in dopamine-dependent locomotor activation. Anatomically, CNS-stimulant drug discrimination may depend primarily on mesolimbic dopamine systems.

Keywords

Stereotyped Behavior Drug Discrimination Atypical Antipsychotic Drug Central Nervous System Stimulant Discriminative Stimulus Property 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aceto MD, Rosecrans J A, Young R, Glennon RA (1984) Similarity between (+)-amphetamine and amfonelic acid. Pharmacol Biochem Behav 20:635–637PubMedCrossRefGoogle Scholar
  2. Andersen P, Braestrup C (1987) Evidence for different states of the dopamine D1 receptor. J Neurochem 48:1667–1672PubMedCrossRefGoogle Scholar
  3. Andersen PH, Gronvald FC, Janssen JA (1985) A comparison between dopamine-stimulated adenylate cyclase and 3H-SCH 23390 binding in rat striatum. Life Sci 37:1971–1983PubMedCrossRefGoogle Scholar
  4. Arat, J (1983) Neuroleptic inhibition of 6,7-ADTN-induced hyperactivity after injection into the nucleus accumbens. Specificity and comparison with other models. Eur J Pharmacol 90:47- 55CrossRefGoogle Scholar
  5. Arnt J (1985) Antistereotypic effects of dopamine D-l and D-2 antagonists after intrastriatal injection in rats. Pharmacological and regional specificity. Naunyn-Schmiedeberg’s Arch Pharmacol 330:97–104CrossRefGoogle Scholar
  6. Arnt J, Hyttel J (1984) Differential inhibition by dopamine D-l and D-2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions. Eur J Pharmacol 102:349–354PubMedCrossRefGoogle Scholar
  7. Bartholini G (1976) Differential effect of neuroleptic drugs on dopamine turnover in the extrapyramidal and limbic system. J Pharm Pharmacol 28:429–433CrossRefGoogle Scholar
  8. Braestrup C, Scheel-Kriiger J (1976) Methylphenidate-like effect of the antidepressant drug nomifensine (HOE 984). Eur J Pharmacol 38:305–312PubMedCrossRefGoogle Scholar
  9. Breese GR, Mueller RA (1985) SCH 23390 antagonism of a D-2 dopamine agonist depends upon catecholaminergic neurons. Eur J Pharmacol 113:109–114PubMedCrossRefGoogle Scholar
  10. Browne RG, Weissman A (1981) Discriminative stimulus properties of tetrahydrocannabinol: mechanistic studies. J Clin Pharmacol 21:2275–2345Google Scholar
  11. Bueno OFA, Carlini EA, Finkelfarb E, Suzuki JS (1976) 9-Tetrahydrocannabinol, ethanol and amphetamine as discriminative stimuli - generalization tests with other drugs. Psychophar- macologia 46:235–243CrossRefGoogle Scholar
  12. Chiodo LA, Bunney BS (1983) Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J Neurosci 8:lA07-lAl9Google Scholar
  13. Colpaert FC (1982) The pharmacological specificity of opiate-drug discrimination. In: Colpaert FC, Janssen PA (eds) Drug discrimination: applications in CNS pharmacology. Elsevier Biomedical, Amsterdam, pp 3–16Google Scholar
  14. Colpaert FC, Janssen PA (1985) Discriminative stimulus properties of xylazine in rat: discrimi- nability and effects of putative alpha-2-adrenoceptor agonists and antagonists. J Pharmacol Exp Ther 235:521–527PubMedGoogle Scholar
  15. Colpaert FC, Slangen JF (1982) Drug discrimination: applications in CNS pharmacology. Elsevier Biomedical, Amsterdam, pp 3–16Google Scholar
  16. Colpaert FC, Niemegeers CJE, Janssen PAJ (1978) Discriminative stimulus properties of cocaine and d-amphetamine, and antagonism by haloperidol: a comparative study. Neuropharmacology 17:937–942PubMedCrossRefGoogle Scholar
  17. Colpaert FC, Niemegeers CJE, Janssen PAJ (1979) Discriminative stimulus properties of cocaine: neuropharmacological characteristics as derived from stimulus generalization experiments. Pharmacol Biochem Behav 10:535–546PubMedCrossRefGoogle Scholar
  18. Colpaert FC, Niemegeers CJE, Janssen PAJ (1980) Evidence that a preferred substrate for type B monoamine oxidase mediates stimulus properties of MAO inhibitors: a possible role for ß-phenylethylamine in the cocaine cue. Pharmacol Biochem Behav 13:513–517PubMedCrossRefGoogle Scholar
  19. Costall B, Marsden CD, Naylor RJ, Pycoek CJ (1977) Stereotyped behavior patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei. Brain Res 123:89–111CrossRefGoogle Scholar
  20. Creese I (1983) Receptor interactions of neuroleptics. In: Coyle JT, Enna SJ (eds) Neuroleptics: neurochemical, behavioral and clinical perspectives. Raven, New York, pp 183–222Google Scholar
  21. Cunningham KA, Appel JB (1982) Discriminative stimulus properties of cocaine and phen- cyclidine: similarities in the mechanism of action. In: Colpaert FC, Slangen JL (eds) Drug discrimination: applications in CNS pharmacology. Elsevier Biomedical, Amsterdam, pp 181–192Google Scholar
  22. Dawson TM, Gehlert DR, Yamamura HI, Baraett A, Wamsley JK (1985) D-l dopamine receptors in the rat brain: autoradiographic localization using [3H]SCH 23390. Eur J Pharmacol 108:323–325PubMedCrossRefGoogle Scholar
  23. D’Mello GD (1981) A comparison of some behavioral effects of amphetamine and electrical brain stimulation of the mesolimbic dopamine system in rats. Psychopharmacology 7:184- 192CrossRefGoogle Scholar
  24. D’Mello GD, Stolerman IP (1977) Comparison of the discriminative stimulus properties of cocaine and amphetamine in rats. Br J Pharmacol 61:415–422PubMedGoogle Scholar
  25. Emmett-Oglesby MW, Wurst M, Lai H (1983) Discriminative stimulus properties of a small dose of cocaine. Neuropharmacology 22:97–101PubMedCrossRefGoogle Scholar
  26. Ferris RM, White HL, Cooper BR, Maxwell RA, Tang FLM, Beaman OJ, Russell A (1981) Some neurochemical properties of a new antidepressant, bupropion hydrochloride (Wellbu- trin). Drug Dev Res 1:21–35Google Scholar
  27. Gerlach J, Korsgaard S, Lund Laursen A, Noring U, Paulsen UJ (1984) New drugs and perspectives in antipsychotic treatment. Clin Neuropharmacol 7:550–551Google Scholar
  28. Glennon RA, Schechter MD, Rosecrans JA (1984 a) Discriminative stimulus properties of S(—)- and R(+)-cathinone, (+)-cathine and several structural modifications. Pharmacol Biochem Behav 21:1–3PubMedCrossRefGoogle Scholar
  29. Glennon RA, Young R, Hauck AE, McKenny JD (1984 b) Structure-activity studies on amphetamine analogs using drug discrimination methodology. Pharmacol Biochem Behav 21:895— 901PubMedCrossRefGoogle Scholar
  30. Goudie AJ (1983) Discriminative stimulus properties in an operant task of ß-phenylethylamine. In: Colpaert FC, Slangen JL (eds) Drug discrimination: applications in CNS pharmacology. Elsevier Biomedical, Amsterdam, pp 165–180Google Scholar
  31. Grome J J, McCulloch J (1983) The effects of apomorphine upon local cerebral glucose utilization in conscious rats and in rats anesthesized with chloral hydrate. J Neurochem 40:569- 576PubMedCrossRefGoogle Scholar
  32. Heikkila RE, Manzino L (1984) Behavioral properties of GBR 12909, GBR 13069 and GBR 13098: specific inhibitors of dopamine uptake. Eur J Pharmacol 103:241–248PubMedCrossRefGoogle Scholar
  33. Hernandez LL, Holohean AM, Appel JB (1978) Effects of opiates on the discriminative stimulus properties of dopamine agonists. Pharmacol Biochem Behav 9:459–461PubMedCrossRefGoogle Scholar
  34. Ho BT, Huang J-T (1975) Role of dopamine in d-amphetamine-induced discriminative responding. Pharmacol Biochem Behav 3:1085–1092PubMedCrossRefGoogle Scholar
  35. Ho BT, McKenna M (1978) Discriminative stimulus properties of central stimulants. In: Ho BT, Richards DW III, Chute DL (eds) Drug discrimination and state dependent learning. Academic, New York, pp 67–77Google Scholar
  36. Holloway FA, Michaelis R, Huerta PL (1985) Caffeine-phenylephylamine combinations mimic the amphetamine discriminative cue. Life Sci 36:723–730CrossRefGoogle Scholar
  37. Huan J-T, Ho BT (1974) The effect of pretreatment with iproniazid on the behavioral activities of jS-phenylethylamine in rats. Psychopharmacologia 35:77–81CrossRefGoogle Scholar
  38. Hyttel J, Larsen J-J (1985) Neurochemical profile of Lu 19–005, a potent inhibitor of uptake of dopamine, noradrenaline, and serotonin. J Neurochem 44:1615–1622PubMedCrossRefGoogle Scholar
  39. Jarbe TUC (1978) Cocaine as a discriminative cue in rats: interactions with neuroleptics and other drugs. Psychopharmacology 59:183–187PubMedCrossRefGoogle Scholar
  40. Jones CN, Hill HF, Harris RT (1974) Discriminative response control by ¿/-amphetamine and related compounds in the rat. Psychopharmacologia 36:347–356PubMedCrossRefGoogle Scholar
  41. Kebabian JW, Agui T, van Oene JC, Shigematsu K, Saavedra JM (1986) The Dx dopamine receptor: new perspectives. Trends Pharmacol Sci 7:96–99CrossRefGoogle Scholar
  42. Keller HH, Schaffner R, Carruba MO, Burkard WP, Pieri M, Bonetti EP, Scherschlicht R, Do Prada M, Maefely WE (1982) Diclofensin (Ro 8–4650) - a potent inhibitor of monoamine uptake. In: Costa E, Racagni G (eds) Typical and atypical antidepressants: molecular mechanisms. Raven, New York, pp 249–263Google Scholar
  43. Kelly E, Nahorshi SR (1986) Functional activation of DA D-l and D-2 receptors by endogenous released dopamine in the rat striatum. Br J Pharmacol 88:305Google Scholar
  44. Köhler C, Haglund L, Ögren S-O, Ängeby T (1981) Regional blockade by neuroleptic drugs of in vivo 3H-spiperone binding in the rat brain. Relation to blockade of apomorphine induced hyperactivity and stereotypies. J Neural Transm 52:163–173PubMedCrossRefGoogle Scholar
  45. Kuhn DM, Appel JB, Greenberg I (1974) An analysis of some discriminative properties of d- amphetamine. Psychopharmacologia 39:57–66PubMedCrossRefGoogle Scholar
  46. Langston JW (1985) Mechanism of MPTP toxicity: more answers, more questions. Trends Pharmacol Sci 6:375–378CrossRefGoogle Scholar
  47. Louilot A, Gonon F, Buda M, Simon H, Le Moal M, Pujol JF (1985) Effects of d- and /-amphetamine on dopamine metabolism and ascorbic acid levels in nucleus accumbens and olfactory tubercle as studied by in vivo differential pulse voltammetry. Brain Res 336:235–263CrossRefGoogle Scholar
  48. Lyon M, Robbins TW (1975) The action of central nervous system stimulant drugs: a general theory concerning amphetamine effects. In: Essman WB, Valzelli L (eds) Current developments in psychopharmacology, vol 2. Spectrum, New York, pp 80–163Google Scholar
  49. McKenna ML, Ho BT (1979) The role of dopamine in the discriminative stimulus properties of cocaine. Neuropharmacology 19:297–303CrossRefGoogle Scholar
  50. Memo M, Pradhan S, Hanbauer I (1981) Cocaine-induced supersensitivity of striatal dopamine receptors: role of endogenous calmodulin. Neuropharmacology 20:1145–1150PubMedCrossRefGoogle Scholar
  51. Nielsen EB (1981) Rapid decline of stereotyped behavior in rats during constant one-week amphetamine administration via implanted osmotic ALZET minipumps. Pharmacol Biochem Behav 15:161–165PubMedCrossRefGoogle Scholar
  52. Nielsen EB, Jepsen SA (1985) Antagonism of the amphetamine cue by both classical and atypical antipsychotic drugs. Eur J Pharmacol 111:167–176PubMedCrossRefGoogle Scholar
  53. Nielsen EB, Scheel-Krüger J (1986) Cueing effects of amphetamine and LSD: elicitation by direct microinjection of the drugs into the nucleus accumbens. Eur J Pharmacol 125:85–92PubMedCrossRefGoogle Scholar
  54. Porsolt RD, Pawalec C, Jalfre M (1982) Use of a drug discrimination procedure to detect amphetamine-like effects of antidepressants. In: Colpaert FC, Slangen JL (eds) Drug discrimination: applications in CNS pharmacology. Elsevier Biomedical, Amsterdam, pp 193–202Google Scholar
  55. Porsolt RD, Pawelec C, Roux S, Jalfre M (1984) Discrimination of the amphetamine cue. Effects of A, B and mixed type inhibitors of monoamine oxidase. Neuropharmacology 23:569–573PubMedCrossRefGoogle Scholar
  56. Randrup A, Kjellberg B, Schiörring E, Scheel-Krüger J, Fog R, Munkvad I (1980) Stereotyped behavior and its relevance for testing neuroleptics. In: Hoffmeister F, Stille G (eds) Psychotropic agents, vol 1. Springer, Berlin Heidelberg New York, pp 97–110CrossRefGoogle Scholar
  57. Robbins TW, Everett BJ (1982) Functional studies of the central catecholamines. Int Rev Neuro- biol 23:303–365CrossRefGoogle Scholar
  58. Sakurai Y, Hisashi O, Shimazoe T, Kataoka Y, Fujiwara M, Ueki S (1985) Δ9Tetrahydrocannabinol elicited ipsilateral circling behavior in rats with unilateral nigral lesion. Life Sci 37:2181–2185PubMedCrossRefGoogle Scholar
  59. Schechter MD (1977) Amphetamine discrimination as a test for anti-Parkinsonism drugs. Eur J Pharmacol 44:51–56PubMedCrossRefGoogle Scholar
  60. Schechter MD (1978) Stimulus properties of d-amphetamine as compared to l-amphetamine. Eur J Pharmacol 47:461–464PubMedCrossRefGoogle Scholar
  61. Schechter MD (1979) Effect of neuroleptics and tricyclic antidepressants upon d-amphetamine discrimination. Pharmacol Biochem Behav 12:1–5CrossRefGoogle Scholar
  62. Schechter MD, Cook PG (1975) Dopaminergic mediation of the interoceptive cue produced by d-amphetamine in rats. Psychopharmacologia 42:185–193PubMedCrossRefGoogle Scholar
  63. Scheel-Krüger J (1971) Comparative studies of various amphetamine analogues demonstrating different interactions with the metabolism of the catecholamines in the brain. Eur J Pharmacol 14:47–59PubMedCrossRefGoogle Scholar
  64. Scheel-Krüger J, Braestrup C, Nielsen M, Golembiowska K, Mogilnicka E (1977) Cocaine: discussion on the role of dopamine in the biochemical mechanism of action. In: Ellingwood EH, Kilbey MM (eds) Cocaine and other stimulants. Advances in behavioral biology. Plenum, New York, pp 373–407Google Scholar
  65. Shearman GT, Lai H (1981) Discriminative stimulus properties of cocaine related to an anxio- genic action. Prog Neuro-psychopharm 5:57–63CrossRefGoogle Scholar
  66. Silverman PB, Ho BT (1977) Characterization of discriminative response control by psychomotor stimulants. In: Lai H (ed) Discriminative stimulus properties of drugs. Plenum, New York, pp 107–119Google Scholar
  67. Snoddy AM, Tessel RE (1983) Nisoxetine and amphetamine share discriminative stimulus properties in mice. Pharmacol Biochem Behav 19:205–210PubMedCrossRefGoogle Scholar
  68. Stolerman IP, D’Mello GD (1981) Role of training conditions in discrimination of central nervous system stimulants by rats. Psychopharmacology 73:295–303PubMedCrossRefGoogle Scholar
  69. Stoof JC, Kebabian JW (1981) Opposing roles for D-l and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature 294:366–368PubMedCrossRefGoogle Scholar
  70. Truex LL, Foreman MM, Rigs RM, Nichols DE (1985) Effects of modifications of the 4-(3,4- dihydroxyphenyl)-l,2,3,4-tetrahydro-isoquinoline structure on dopamine sensitive rat retinal adenylate cyclase activity. Soc Neurosci 11:1094Google Scholar
  71. Volpi M, Shaafi RI, Epstein PM, Andrenyak DM, Feinstein MB (1981) Local anaesthetics, me- paerine, and propranolol are antagonists of calmodulin. Proc Natl Acad Sci USA 78:795- 799PubMedCrossRefGoogle Scholar
  72. White FJ, Wang RY (1983) Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. Science 221:1054–1057PubMedCrossRefGoogle Scholar
  73. White FJ, Wang RY (1986) Electrophysiological evidence of both D-l and D-2 dopamine receptors in the rat nucleus accumbens. J Neurosci 6:1–7Google Scholar
  74. Wiesel F-A, Sedvall G (1975) Effect of antipsychotic drugs on homovanillic acid levels in striatum and olfactory tubercle of the rat. Eur J Pharmacol 30:364–367PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • E. B. Nielsen
    • 1
  • J. Scheel-Krüger
    • 2
  1. 1.Pharmaceuticals R & D, Department of PharmacologyNOVO Industri A/SBagsvaerdDenmark
  2. 2.Psychopharmacological Research LaboratorySct. Hans Mental HospitalRoskildeDenmark

Personalised recommendations